GHRH analogue
Sermorelin
Answer
Sermorelin is not authorised on any of the 10 registers read, and 1 of them holds no reading for it. No trial states a phase. It has 27 registered trials, 1 of them running.
RegulatorTrial register10 regulators' registers, read 2026-08-31 to 2026-10-03 · ClinicalTrials.gov, read 2026-10-03
Not medical, legal or regulatory advice.
27 trials by status
Trial registerClinicalTrials.gov · read 2026-10-03 · 5 trials have posted results
Trials first submitted per year
Trial registerClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 11 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).
Status by jurisdiction
World map| Where | Status | Register | Read |
|---|---|---|---|
| United States | Not on the register | FDA, openfda | 2026-10-03 |
| European Union | Not on the register | EMA, ema | 2026-08-31 |
| United Kingdom | Not on the register | MHRA, uk-mhra | 2026-09-03 |
| Canada | Not on the register | Health Canada, ca-dpd | 2026-09-03 |
| Australia | Status unknown | TGA, au-artg | not read |
| Switzerland | Not on the register | Swissmedic, ch-swissmedic | 2026-09-03 |
| Brazil | Not on the register | ANVISA, br-anvisa | 2026-09-03 |
| Serbia | Not on the register | ALIMS, rs-alims | 2026-09-03 |
| Singapore | Not on the register | HSA, sg-hsa | 2026-09-03 |
| Turkey | Not on the register | TITCK, tr-titck | 2026-09-03 |
An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.
CHANGE ALERTS
Get an email when this changes
One email when the status of Sermorelin changes on the register. You confirm your address first.
ENFORCEMENT AND OFFICIAL ACTIONS
1 action by named authorities
Enforcement actions, board positions and payer rules that name Sermorelin, quoted from the source document. These are not approval decisions. This list shows the actions found so far. It is not a complete list: no authority publishes one.
| US-CAenforcement | California Board of Pharmacy, 2023-12-04 On or about May 16, 2017, a compounding pharmacist, A.J.C., employed as a compounding pharmacist by Respondent provided a video presentation wherein A.J.C. promotes Sermorelin and other peptides and posted on Respondent’s YouTube.com channel/account. In this presentation A.J.C. makes several false statements promoting Sermorelin and other Peptides and fails to note at any time that none of these products are FDA approved or legal to be compounded with in the United States.California Board of Pharmacy, First Amended Accusation and First Amended Statement of Issues, Case Nos. 7160 and 7171, paragraph 67 |
|---|
REGISTERED TRIALS
Newest 10 of 27 trials
| NCT06554717 | Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV currently recruiting participants · register updated 2026-05-19 |
|---|---|
| NCT03375788 | Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk completed · register updated 2025-11-20 |
| NCT00720902 | Adult Growth Hormone Deficiency and Cardiovascular Risk terminated before completion · register updated 2022-11-16 |
| NCT00608023 | TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy completed · register updated 2022-09-30 |
| NCT02196831 | Tesamorelin Effects on Liver Fat and Histology in HIV completed · register updated 2020-01-27 |
| NCT02553603 | The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment completed · register updated 2019-11-04 |
| NCT00791843 | The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure completed · register updated 2019-07-09 |
| NCT01410799 | Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly terminated before completion · register updated 2019-05-24 |
| NCT00675506 | Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese completed · register updated 2017-12-13 |
| NCT01263717 | Effects of Growth Hormone Releasing Hormone in HIV completed · register updated 2017-10-30 |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.